share_log

OptimizeRx Launches Micro-Neighborhood Targeting, Offered On The Co's Dynamic Audience Activation Platform, Further Unifing Outreach To Patient And Provider Audiences Via The Incorporation Of Brand Eligibility Signals To Consumer Marketing

OptimizeRx Launches Micro-Neighborhood Targeting, Offered On The Co's Dynamic Audience Activation Platform, Further Unifing Outreach To Patient And Provider Audiences Via The Incorporation Of Brand Eligibility Signals To Consumer Marketing

optimizerx推出微邻域定位,该公司的动态受众激活平台上提供品牌资格信号的消费者营销进一步统一了对患者和提供者受众的外展
Benzinga ·  09/09 12:04

The availability of Micro-Neighborhood Targeting on the Company's Dynamic Audience Activation Platform meets the demand of life sciences marketers by synchronizing consumer and physician marketing

该公司的动态受众激活平台上提供的微邻域定向功能可通过同步消费者和医生的营销来满足生命科学营销人员的需求

OptimizeRx presents panel session at Digital Pharma East: Unlocking Opportunity through HCP+DTC Alignment in Omnichannel Oncology Marketing

OptimizerX 在 Digital Pharma East 上举行小组会议:通过全渠道肿瘤学营销中的HCP+DTC协调释放机遇

WALTHAM, Ma., Sept. 09, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and prospective patients, today announces the leading AI-driven marketing technology for healthcare consumers, Micro-Neighborhood Targeting (MNT), offered on the Company's Dynamic Audience Activation Platform (DAAP), which now further unifies outreach to patient and provider audiences via the incorporation of brand eligibility signals to consumer marketing. This enhancement to DAAP enables pharmaceutical brands to deliver synchronized, AI-guided Direct-to-Consumer (DTC) and HCP campaigns, with the mission to improve the dialogue between patients and physicians throughout the treatment journey.

马萨诸塞州沃尔瑟姆,2024年9月9日(GLOBE NEWSWIRE)——帮助生命科学公司接触和吸引医疗保健专业人员(HCP)和潜在患者的医疗保健技术解决方案的领先提供商OptimizerX公司(“公司”)(纳斯达克股票代码:OPRX)今天宣布在公司的动态受众激活平台(DAAP)上为医疗保健消费者提供领先的人工智能驱动营销技术——微邻域定位(MNT),它现在通过整合品牌资格信号,进一步统一了对患者和医疗服务提供者受众的宣传到消费者营销。对DAAP的这一增强使制药品牌能够同步开展由人工智能指导的直接面向消费者(DTC)和HCP活动,其使命是改善整个治疗过程中患者与医生之间的对话。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发